Annual Review of Cancer Biology

Papers
(The H4-Index of Annual Review of Cancer Biology is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Is There a Clinical Future for IDO1 Inhibitors After the Failure of Epacadostat in Melanoma?116
Regulatory T Cells in Cancer82
Lactate and Acidity in the Cancer Microenvironment64
Metabolism in the Tumor Microenvironment61
RNA Modifications in Cancer: Functions, Mechanisms, and Therapeutic Implications58
The Pleiotropic Role of the KEAP1/NRF2 Pathway in Cancer43
The Epithelial-to-Mesenchymal Transition in Development and Cancer43
Mitophagy and Mitochondrial Dysfunction in Cancer43
Targeting MYC Proteins for Tumor Therapy41
Investigating Tumor Heterogeneity in Mouse Models39
WNT and β-Catenin in Cancer: Genes and Therapy38
The Role of Translation Control in Tumorigenesis and Its Therapeutic Implications37
Reactivation of Endogenous Retroelements in Cancer Development and Therapy36
Telomeres and Cancer: Resolving the Paradox30
Metabolic Drivers in Hereditary Cancer Syndromes30
The Bidirectional Relationship Between Cancer Epigenetics and Metabolism29
Biomarkers for Response to Immune Checkpoint Blockade28
Immunometabolism in the Tumor Microenvironment27
Small-Molecule Approaches to Targeted Protein Degradation26
Humanized Mouse Models to Evaluate Cancer Immunotherapeutics26
Cancer-Associated Cachexia: A Systemic Consequence of Cancer Progression25
Toward Targeting Antiapoptotic MCL-1 for Cancer Therapy25
Reinventing Radiobiology in the Light of FLASH Radiotherapy23
0.016113996505737